Europese Unie - Nederlands - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozine propaandiol monohydraat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - geneesmiddelen die worden gebruikt bij diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. naast andere geneesmiddelen voor de behandeling van type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 en 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Europese Unie - Nederlands - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozine propaandiol monohydraat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - geneesmiddelen die worden gebruikt bij diabetes - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. naast andere geneesmiddelen voor de behandeling van type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 en 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Europese Unie - Nederlands - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - geneesmiddelen die worden gebruikt bij diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 en 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hcs s.p.r.l.-b.v.b.a. - dapagliflozinepropanediolmonohydraat 6,15 mg - eq. dapagliflozine 5 mg - filmomhulde tablet - dapagliflozin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hcs s.p.r.l.-b.v.b.a. - dapagliflozinepropanediolmonohydraat 12,3 mg - eq. dapagliflozine 10 mg - filmomhulde tablet - dapagliflozin

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dapagliflozine 10 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 6000 ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; natriumlaurilsulfaat (e 487) ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dapagliflozine 5 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 6000 ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; natriumlaurilsulfaat (e 487) ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)